Translatome profiling in fatal familial insomnia implicates TOR signaling in somatostatin neurons.
Susanne BauerLars DittrichLech KaczmarczykMelvin SchleifRui BenfeitasWalker Scot JacksonPublished in: Life science alliance (2022)
Selective neuronal vulnerability is common in neurodegenerative diseases but poorly understood. In genetic prion diseases, including fatal familial insomnia (FFI) and Creutzfeldt-Jakob disease (CJD), different mutations in the <i>Prnp</i> gene manifest as clinically and neuropathologically distinct diseases. Here we report with electroencephalography studies that theta waves are mildly increased in 21 mo old knock-in mice modeling FFI and CJD and that sleep is mildy affected in FFI mice. To define affected cell types, we analyzed cell type-specific translatomes from six neuron types of 9 mo old FFI and CJD mice. Somatostatin (SST) neurons responded the strongest in both diseases, with unexpectedly high overlap in genes and pathways. Functional analyses revealed up-regulation of neurodegenerative disease pathways and ribosome and mitochondria biogenesis, and down-regulation of synaptic function and small GTPase-mediated signaling in FFI, implicating down-regulation of mTOR signaling as the root of these changes. In contrast, responses in glutamatergic cerebellar neurons were disease-specific. The high similarity in SST neurons of FFI and CJD mice suggests that a common therapy may be beneficial for multiple genetic prion diseases.
Keyphrases
- high fat diet induced
- genome wide
- spinal cord
- single cell
- copy number
- early onset
- sleep quality
- type diabetes
- magnetic resonance
- physical activity
- magnetic resonance imaging
- computed tomography
- stem cells
- cell therapy
- cell proliferation
- adipose tissue
- transcranial magnetic stimulation
- reactive oxygen species
- endoplasmic reticulum
- bone marrow
- transcription factor
- neuroendocrine tumors
- replacement therapy